{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:04:16Z","timestamp":1740146656022,"version":"3.37.3"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235376","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T22:03:33Z","timestamp":1594073013000},"page":"e0235376","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4493-9357","authenticated-orcid":true,"given":"Artur Mendes","family":"Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia Oliveira","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Filipe","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"4\u20135","key":"pone.0235376.ref001","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.autrev.2014.01.020","article-title":"Diagnosis and classification of autoimmune diabetes mellitus","volume":"13","author":"S Canivell","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"11","key":"pone.0235376.ref002","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.mpmed.2010.08.008","article-title":"What is type 2 diabetes?","volume":"38","author":"G Smushkin","year":"2010","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"pone.0235376.ref003","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus","volume":"37","author":"A Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"issue":"2","key":"pone.0235376.ref004","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1573399810666140421124051","article-title":"Glycaemic Control: A Balancing Act or A Different Approach?","volume":"10","author":"S. Fava","year":"2014","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"pone.0235376.ref005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1479164116679775","article-title":"Gaps and barriers in the control of blood glucose in people with type 2 diabetes","volume":"14","author":"L Blonde","year":"2017","journal-title":"Diabetes Vasc Dis Res"},{"issue":"3","key":"pone.0235376.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2017-019214","article-title":"Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: A retrospective cohort study from a specialised diabetes centre in Denmark","volume":"8","author":"N Safai","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0235376.ref007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-017-2486-7","article-title":"A combination of process of care and clinical target among type 2 diabetes mellitus patients in general medical clinics and specialist diabetes clinics at hospital levels","volume":"17","author":"S Sieng","year":"2017","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0235376.ref008","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.3949\/ccjm.84.s1.07","article-title":"Medical treatment of diabetes mellitus","volume":"84","author":"M. Skugor","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"pone.0235376.ref009","unstructured":"NICE. Type 2 diabetes in adults: management. NICE Guidel (NG 28; 2 December 2015). 2019;(Last update May 2017). https:\/\/www.nice.org.uk\/guidance\/ng28\/resources\/type-2-diabetes-in-adults-management-pdf-1837338615493."},{"issue":"8","key":"pone.0235376.ref010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/M17-0939","article-title":"Hemoglobin A1ctargets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American college of physicians","volume":"168","author":"A Qaseem","year":"2018","journal-title":"Ann Intern Med"},{"key":"pone.0235376.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9389265","article-title":"Patient-related determinants of glycaemic control in people with type 2 diabetes in the gulf cooperation council countries: A systematic review","volume":"25","author":"MJ Alramadan","year":"2018","journal-title":"J Diabetes Res"},{"key":"pone.0235376.ref012","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc10-1504","article-title":"Regional, geographic, and racial\/ethnic variation in glycemic control in a national sample of veterans with diabetes","volume":"34","author":"LE Egede","year":"2011","journal-title":"Diabetes Care"},{"key":"pone.0235376.ref013","doi-asserted-by":"crossref","first-page":"e003336","DOI":"10.1136\/bmjopen-2013-003336","article-title":"Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study","volume":"3","author":"LV Viana","year":"2013","journal-title":"BMJ Open"},{"key":"pone.0235376.ref014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.diabres.2011.12.003","article-title":"Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age","volume":"96","author":"A Nagrebetsky","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"pone.0235376.ref015","first-page":"314","article-title":"Fatores associados ao controle glic\u00eamico em pacientes com diabetes tipo 2","volume":"54","author":"D Panarotto","year":"2008","journal-title":"Rev Assoc Med Bras"},{"issue":"3","key":"pone.0235376.ref016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/2042018814544890","article-title":"Level of A1c control and its predictors among Lebanese type 2 diabetic patients","volume":"5","author":"H Noureddine","year":"2014","journal-title":"Ther Adv Endocrinol Metab"},{"key":"pone.0235376.ref017","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2458-13-602","article-title":"Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables","volume":"13","author":"L-N Ji","year":"2013","journal-title":"BMC Public Health"},{"key":"pone.0235376.ref018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jdiacomp.2008.12.008","article-title":"Factors associated with poor glycemic control among patients with type 2 diabetes","volume":"24","author":"M Khattab","year":"2010","journal-title":"J Diabetes Complications"},{"issue":"10","key":"pone.0235376.ref019","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/ijcp.12179","article-title":"Prognostic implications of DPP-4 inhibitor vs sulfonylurea use on top of metformin in a real world setting\u2014results of the 1 year follow-up of the prospective DiaRegis registry","volume":"67","author":"AK Gitt","year":"2013","journal-title":"Int J Clin Pract"},{"issue":"8","key":"pone.0235376.ref020","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/dom.12673","article-title":"Change in glycated haemoglobin levels after initiating second-line therapy in type 2 diabetes: a primary care database study","volume":"18","author":"W Rathmann","year":"2016","journal-title":"Diabetes, Obes Metab"},{"issue":"5","key":"pone.0235376.ref021","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1185\/03007995.2013.875464","article-title":"Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany","volume":"30","author":"R G\u00f6ke","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"pone.0235376.ref022","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/dom.12233","article-title":"Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis","volume":"16","author":"OJ Phung","year":"2014","journal-title":"Diabetes, Obes Metab"},{"issue":"7","key":"pone.0235376.ref023","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jdiacomp.2016.05.012","article-title":"Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study","volume":"30","author":"I Goldshtein","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"May","key":"pone.0235376.ref024","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/dc13-1901","article-title":"Second-line agents for glycemic control for type 2 diabetes: are newer agents better?","volume":"37","author":"Y Zhang","year":"2014","journal-title":"Diabetes Care"},{"key":"pone.0235376.ref025","doi-asserted-by":"crossref","first-page":"e1771","DOI":"10.1136\/bmj.e1771","article-title":"Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses","volume":"344","author":"B Hemmingsen","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"pone.0235376.ref026","first-page":"1","article-title":"Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus\u2014the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial","volume":"6","author":"L Lundby-Christensen","year":"2016","journal-title":"BMJ Open"},{"issue":"7","key":"pone.0235376.ref027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dmrr.2913","article-title":"Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes","volume":"33","author":"Y Zhang","year":"2017","journal-title":"Diabetes Metab Res Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T22:03:50Z","timestamp":1594073030000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235376"}},"subtitle":[],"editor":[{"given":"Manal S.","family":"Fawzy","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235376","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,7,6]]}}}